Hobo, Willemijn-2015.jpg
Dr. Willemijn Hobo 

Assistant Professor

Cancer development and immune defense


Research interests include immunology and hemato-oncology, with a specific focus on the development and improvement of immunotherapeutic strategies to boost anti-tumor immunity in patients with hematological cancers. Major current projects include the investigation of: 1) frequencies and functionality of tumor-reactive T cell responses in patients after allogeneic stem cell transplantation; 2) the involvement of co-inhibitory molecule signaling in functional impairment of tumor-reactive T cell responses; 3) novel strategies to interfere with co-inhibitory signaling pathways; 4) exploration of dendritic cell vaccination to boost anti-tumor T cell responses after allogeneic stem cell transplantation.

Willemijn Hobo is postdoc at the Department of Laboratory Medicine – Laboratory of Hematology. In addition, she is Deskundige ATMPs for manufacturing of cellular therapeutic products, and is involved as laboratory investigator in various clinical DC vaccination trials. She obtained her PhD in Medical Sciences Cum Laude in 2013 (Radboud University Nijmegen, the Netherlands). In 2012 she was awarded the Bas Mulder Award for her postdoctoral studies.


National & International Personal Prizes & Awards

  • 2015: €1750 René Vogels travel grant by the René Vogels Foundation for work visit at the Antwerp University Hospital.
  • 2014: $5000 George Santos award, Best clinical science article by a new investigator, American Society of Blood and Marrow Transplantation.
  • 2013: €1000 Best thesis award of the Dutch Society for Immunology (NVVI), Noordwijkerhout.
  • 2013: €1250 Travel Grant of the Dutch Society of Immunology (NVVI) for work visit at Yale University, New Haven, CT .
  • 2010: PhD Award for best presentation at Dutch Tumor Immunology Meeting, Breukelen, the Netherlands.

Secondary functions


<< go back